Señales en vivo de ADMP | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 sept 2023 @ 15:59):

Stats
Volumen de hoy	119 482
Volumen promedio	3.11M
Capitalización de mercado	7.25M
EPS	$0 ( 2024-03-14 )
Próxima fecha de ganancias	( $0 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0764
ATR14	$0.190 (30.44%)

Insider Trading

Date	Person	Action	Amount	type
2023-10-23	Dorbin John W. Jr.	Buy	70 000	Employee Stock Option (right to buy)
2023-10-23	Dorbin John W. Jr.	Buy	0
2023-10-16	Cohen Seth	Buy	151 416	Employee Stock Option (right to buy)
2023-10-16	Cohen Seth	Buy	0
2023-09-15	Versi Ebrahim	Buy	729 200	Common Stock

INSIDER POWER
93.12
Last 88 transactions
Buy: 1 947 813 \| Sell: 1 308 563

Volumen Correlación

Largo: -0.04 (neutral)

Corto: -0.22 (neutral)

Signal:(43.501) Neutral

Adamis Pharmaceuticals Correlación

10 Correlaciones Más Positivas
AGRX	0.964
VLCN	0.956
VRAY	0.949
HAIN	0.947
NDLS	0.944
IONM	0.943
NSTG	0.943
ENSC	0.941
CLPT	0.941
NEXT	0.938

10 Correlaciones Más Negativas
ADSE	-0.961
NWLI	-0.96
PRSRU	-0.954
EVLV	-0.942
BTWN	-0.934
STCN	-0.932
CCRC	-0.932
ARNA	-0.931
DSEY	-0.931
DMRC	-0.928

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Adamis Pharmaceuticals Correlación - Moneda/Commodity

0.70
( moderate )

0.66
( moderate )

0.00
( neutral )

0.74
( moderate )

-0.30
( neutral )

-0.62
( weak negative )

Adamis Pharmaceuticals Finanzas

Annual	2022
Ingresos:	$4.76M
Beneficio Bruto:	$-1.43M (-30.10 %)
EPS:	$-12.24

FY	2022
Ingresos:	$4.76M
Beneficio Bruto:	$-1.43M (-30.10 %)
EPS:	$-12.24

FY	2021
Ingresos:	$2.21M
Beneficio Bruto:	$-4.66M (-211.14 %)
EPS:	$-0.320

FY	2020
Ingresos:	$16.53M
Beneficio Bruto:	$1.63M (9.88 %)
EPS:	$-0.640

Financial Reports:

No articles found.

Adamis Pharmaceuticals

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the treatment of asthma; and naloxone injection for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, and injectables; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California.